Chapter/Section Purchase

1 Pemetrexed Drug Market Overview
1.1 Product Overview and Scope of Pemetrexed Drug
1.2 Pemetrexed Drug Segment by Type
1.2.1 Global Pemetrexed Drug Sales Growth Rate Comparison by Type (2023-2029)
1.2.2 100 mg lyophilized powder/vial
1.2.3 500 mg lyophilized powder/vial
1.3 Pemetrexed Drug Segment by Application
1.3.1 Global Pemetrexed Drug Sales Comparison by Application: (2023-2029)
1.3.2 Pleural mesothelioma
1.3.3 Non-small cell lung cancer
1.4 Global Pemetrexed Drug Market Size Estimates and Forecasts
1.4.1 Global Pemetrexed Drug Revenue 2018-2029
1.4.2 Global Pemetrexed Drug Sales 2018-2029
1.4.3 Pemetrexed Drug Market Size by Region: 2018 Versus 2022 Versus 2029
2 Pemetrexed Drug Market Competition by Manufacturers
2.1 Global Pemetrexed Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pemetrexed Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pemetrexed Drug Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Pemetrexed Drug Manufacturing Sites, Area Served, Product Type
2.5 Pemetrexed Drug Market Competitive Situation and Trends
2.5.1 Pemetrexed Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pemetrexed Drug Players Market Share by Revenue
2.5.3 Global Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pemetrexed Drug Retrospective Market Scenario by Region
3.1 Global Pemetrexed Drug Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Pemetrexed Drug Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Pemetrexed Drug Market Facts & Figures by Country
3.3.1 North America Pemetrexed Drug Sales by Country
3.3.2 North America Pemetrexed Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pemetrexed Drug Market Facts & Figures by Country
3.4.1 Europe Pemetrexed Drug Sales by Country
3.4.2 Europe Pemetrexed Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pemetrexed Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Pemetrexed Drug Sales by Region
3.5.2 Asia Pacific Pemetrexed Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pemetrexed Drug Market Facts & Figures by Country
3.6.1 Latin America Pemetrexed Drug Sales by Country
3.6.2 Latin America Pemetrexed Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pemetrexed Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Pemetrexed Drug Sales by Country
3.7.2 Middle East and Africa Pemetrexed Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pemetrexed Drug Historic Market Analysis by Type
4.1 Global Pemetrexed Drug Sales Market Share by Type (2018-2023)
4.2 Global Pemetrexed Drug Revenue Market Share by Type (2018-2023)
4.3 Global Pemetrexed Drug Price by Type (2018-2023)
5 Global Pemetrexed Drug Historic Market Analysis by Application
5.1 Global Pemetrexed Drug Sales Market Share by Application (2018-2023)
5.2 Global Pemetrexed Drug Revenue Market Share by Application (2018-2023)
5.3 Global Pemetrexed Drug Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Corporation Information
6.1.2 Eli Lilly and Company Description and Business Overview
6.1.3 Eli Lilly and Company Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Eli Lilly and Company Pemetrexed Drug Product Portfolio
6.1.5 Eli Lilly and Company Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Pemetrexed Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teva Pemetrexed Drug Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Eagle Pharmaceuticals
6.4.1 Eagle Pharmaceuticals Corporation Information
6.4.2 Eagle Pharmaceuticals Description and Business Overview
6.4.3 Eagle Pharmaceuticals Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eagle Pharmaceuticals Pemetrexed Drug Product Portfolio
6.4.5 Eagle Pharmaceuticals Recent Developments/Updates
6.5 APOTEX
6.5.1 APOTEX Corporation Information
6.5.2 APOTEX Description and Business Overview
6.5.3 APOTEX Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 APOTEX Pemetrexed Drug Product Portfolio
6.5.5 APOTEX Recent Developments/Updates
6.6 Qilu Pharmaceutical
6.6.1 Qilu Pharmaceutical Corporation Information
6.6.2 Qilu Pharmaceutical Description and Business Overview
6.6.3 Qilu Pharmaceutical Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Qilu Pharmaceutical Pemetrexed Drug Product Portfolio
6.6.5 Qilu Pharmaceutical Recent Developments/Updates
6.7 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biocon Pemetrexed Drug Product Portfolio
6.7.5 Biocon Recent Developments/Updates
7 Pemetrexed Drug Manufacturing Cost Analysis
7.1 Pemetrexed Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pemetrexed Drug
7.4 Pemetrexed Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pemetrexed Drug Distributors List
8.3 Pemetrexed Drug Customers
9 Pemetrexed Drug Market Dynamics
9.1 Pemetrexed Drug Industry Trends
9.2 Pemetrexed Drug Market Drivers
9.3 Pemetrexed Drug Market Challenges
9.4 Pemetrexed Drug Market Restraints
10 Global Market Forecast
10.1 Pemetrexed Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pemetrexed Drug by Type (2024-2029)
10.1.2 Global Forecasted Revenue of Pemetrexed Drug by Type (2024-2029)
10.2 Pemetrexed Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pemetrexed Drug by Application (2024-2029)
10.2.2 Global Forecasted Revenue of Pemetrexed Drug by Application (2024-2029)
10.3 Pemetrexed Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pemetrexed Drug by Region (2024-2029)
10.3.2 Global Forecasted Revenue of Pemetrexed Drug by Region (2024-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer